Patent ID: 8778922
Filing Date: 2014-07-15
Classification: A61K,A61P

Abstract:
1. An oral pharmaceutical composition comprising: 10-30% w/w of a steroidal compound, wherein the steroidal compound is testosterone undecanoate; 10-30% w/w of a hydrophilic carrier, wherein the hydrophilic carrier is a hydrophilic surfactant; 40-70% w/w of a lipophilic carrier, wherein the lipophilic carrier is a lipophilic surfactant, and wherein the lipophilic surfactant is glyceryl monolinoleate; and 1-20% w/w of a solidifying agent, wherein said pharmaceutical composition has from 70 mg to 150 mg testosterone undecanoate and said oral pharmaceutical composition is a jelly, solid, semi-solid, glassy or paste-like composition in a capsule.